Uveitis Trial, Recruiting NCT04402086 Sponsor: Yale University Condition: Uveitis
Back to Uveitis

Uveitis Trial, Recruiting

NCT04402086
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with rheumatic conditions:

  • You are 18 years old or older and have been diagnosed with a rheumatic autoimmune disease, such as rheumatoid arthritis, lupus, psoriatic arthritis, Sjogren's syndrome, scleroderma, or a similar condition (a fuller list can be confirmed with the trial site)
  • You currently receive your care at a Yale Rheumatology clinic

For healthy volunteers:

  • You are 18 years old or older
  • You do not have any ongoing skin conditions
  • You have not been diagnosed with a rheumatic autoimmune disease such as lupus or rheumatoid arthritis
  • You have a normal body weight range (BMI) (confirm with trial site for exact definition)

Who may not be able to join:

For people with rheumatic conditions:

  • You are not able to give your own informed consent to participate
  • If you are currently pregnant, you would need to wait until after giving birth before taking part in the skin biopsy portion of the study
  • If you are allergic to lidocaine or epinephrine, or have a history of wounds that heal poorly, you would not be able to take part in the skin biopsy portion

For healthy volunteers:

  • You are not able to give your own informed consent to participate
  • You are currently pregnant or breastfeeding (unless the study is specifically focused on pregnant or nursing individuals)
  • You are allergic to lidocaine or epinephrine
  • You have a history of wounds that heal poorly

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Monique Hinchcliff, MD, Yale University

Phone: 203-737-5571

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
4 August 2020
Est. completion
1 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Correlate outcomes and biomarkers of rheumatic diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov